Italiano Terapie Innovative nei Linfomi) prospective multicenter trial treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line

A. Melnyk, A. Rodriguez, W.C. Pugh, F. Cabannillas, Evaluation of the Revised European-American Lymphoma Classification Confirms the Clinical Relevance of Immunophenotype in 560 Cases of Aggressive Non-Hodgkin's Lymphoma Blood. ,vol. 89, pp. 4514- 4520 ,(1997) , 10.1182/BLOOD.V89.12.4514

Elias Campo, N Lee Harris, Elaine S Jaffe, Stefano A Pileri, Harald Stein, Jurgen Thiele, James W Vardiman, None, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues ,(2017)

Christian Gisselbrecht, Dominique Cazals-Hatem, André Bosly, Bertrand Coiffier, Luc Xerri, Eric Lepage, Hervé Tilly, Josette Brière, Reda Bouhabdallah, Corinne Haioun, Jacques Diebold, Françoise Berger, Philippe Gaulard, Prognostic Significance of T-Cell Phenotype in Aggressive Non-Hodgkin's Lymphomas Blood. ,vol. 92, pp. 76- 82 ,(1998) , 10.1182/BLOOD.V92.1.76.413A19_76_82

C Haioun, E Lepage, C Gisselbrecht, Y Bastion, B Coiffier, P Brice, A Bosly, B Dupriez, C Nouvel, H Tilly, P Lederlin, P Biron, J Brière, P Gaulard, F Reyes, Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. Journal of Clinical Oncology. ,vol. 15, pp. 1131- 1137 ,(1997) , 10.1200/JCO.1997.15.3.1131

B Coiffier, F Berger, P A Bryon, J P Magaud, T-cell lymphomas: immunologic, histologic, clinical, and therapeutic analysis of 63 cases. Journal of Clinical Oncology. ,vol. 6, pp. 1584- 1589 ,(1988) , 10.1200/JCO.1988.6.10.1584

S M Ansell, T M Habermann, P J Kurtin, T E Witzig, M G Chen, C Y Li, D J Inwards, J P Colgan, Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. Journal of Clinical Oncology. ,vol. 15, pp. 2296- 2301 ,(1997) , 10.1200/JCO.1997.15.6.2296

S. Ascani, P.L. Zinzani, F. Gherlinzoni, E. Sabattini, A. Briskomatis, A. de Vivo, M. Piccioli, G. Fraternali Orcioni, F. Pieri, A. Goldoni, P.P. Piccaluga, D. Zallocco, R. Burnelli, L. Leoncini, B. Falini, S. Tura, S.A. Pileri, Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification Annals of Oncology. ,vol. 8, pp. 583- 592 ,(1997) , 10.1023/A:1008200307625

W Hryniuk, H Bush, The importance of dose intensity in chemotherapy of metastatic breast cancer. Journal of Clinical Oncology. ,vol. 2, pp. 1281- 1288 ,(1984) , 10.1200/JCO.1984.2.11.1281

Bruce D. Cheson, Sandra J. Horning, Bertr Coiffier, Margaret A. Shipp, Richard I. Fisher, Joseph M. Connors, T. Andrew Lister, Julie Vose, Antonio Grillo-López, Anton Hagenbeek, Fernando Cabanillas, Donald Klippensten, Wolfgang Hiddemann, Ronald Castellino, Nancy L. Harris, James O. Armitage, William Carter, Richard Hoppe, George P. Canellos, Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas Journal of Clinical Oncology. ,vol. 17, pp. 1244- 1244 ,(1999) , 10.1200/JCO.1999.17.4.1244

Massimiliano Manganini, Josée Golay, Alessandro Rambaldi, Martino Introna, Effect of alemtuzumab on neoplastic B cells Haematologica. ,vol. 89, pp. 1476- 1483 ,(2004) , 10.3324/%X